Cargando…
The EMT spectrum and therapeutic opportunities
Carcinomas are phenotypically arrayed along an epithelial–mesenchymal transition (EMT) spectrum, a developmental program currently exploited to understand the acquisition of drug resistance through a re‐routing of growth factor signaling. This review collates the current approaches employed in devel...
Autores principales: | Voon, Dominic C., Huang, Ruby Y., Jackson, Rebecca A., Thiery, Jean P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496500/ https://www.ncbi.nlm.nih.gov/pubmed/28544151 http://dx.doi.org/10.1002/1878-0261.12082 |
Ejemplares similares
-
EMT‐ and MET‐related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities
por: Kahlert, Ulf D., et al.
Publicado: (2017) -
New insights into the role of EMT in tumor immune escape
por: Terry, Stéphane, et al.
Publicado: (2017) -
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
por: Huang, Yuhe, et al.
Publicado: (2022) -
Tumor Budding: The Name is EMT. Partial EMT.
por: Grigore, Alexandru Dan, et al.
Publicado: (2016) -
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
por: Huang, R Y-J, et al.
Publicado: (2013)